|
|
|
|
|
|
|
New Female / STD vaccines can be developed to tackle common sexually transmitted disease such as Chlamydia trachomatis and Herpes Simplex Virus, although it is noteworthy that
males can also transmit these pathogens. Indications such as Recurrent Vulvovaginal Candidiasis (RVVC) and Recurrent Urinary Tract Infections (rUTIs) or Cystitis impact on the quality of life of millions of women.
MarketVIEW products in the Female / STD vaccines segment are available for the following areas. Please click on the tablet below:
***Summer 2020*** New 'snap shot' analyses containing a disease profile and a single country revenue forecast can now be ordered across the range.
*For more information about this product and how to order,
e-mail: orders@vaczine-analytics.com
For UK orders VAT will be added at 20%. TERMS and CONDITIONS of purchase will be made available upon enquiry.
| Documents on this page are available in Portable Document Format (PDF)
|
|
|
|
|
|